Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
Clinical trial NCT00412594 · RECRUITING
Trial details
- NCT number
- NCT00412594
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-10
- Primary completion
- 2027-06-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.